Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Results have been posted for the study; the results section and related dates (e.g., Results First Posted) have been added or updated. Primary and secondary outcome measures are now presented.
    Difference
    0.5%
    Check dated 2025-11-03T13:16:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government funding/operating-status notice for the NIH Clinical Center; removed reference to v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:13:36.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.5%
    Check dated 2025-09-28T23:35:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' link/button was removed.
    Difference
    0.3%
    Check dated 2025-09-14T09:56:16.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T07:56:07.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has added significant new content related to drug safety, nutritional diseases, and various biological factors, while removing specific location details and certain drug-related topics.
    Difference
    7%
    Check dated 2025-08-31T01:06:48.000Z thumbnail image

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.